Ardelyx Stock (NASDAQ: ARDX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 5.480M |
Day Range | - - - |
52 Wk Range | 3.160 - 10.130 |
Market Cap | $1.491B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 15.3% |
Days to Cover | 6.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ardelyx (NASDAQ: ARDX) through any online brokerage.
Other companies in Ardelyx’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Syndax Pharmaceuticals (NASDAQ:SNDX), Day One Biopharmaceutical (NASDAQ:DAWN) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for Ardelyx (NASDAQ: ARDX) was reported by Wedbush on Wednesday, April 17, 2024. The analyst firm set a price target for 14.00 expecting ARDX to rise to within 12 months (a possible 118.41% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Ardelyx (NASDAQ: ARDX) is $6.4099 last updated April 23, 2024 at 7:56 PM EDT.
There are no upcoming dividends for Ardelyx.
Ardelyx’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Ardelyx.
Ardelyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.